annb0t
Top 20
Immutep Limited
Media Release
SYDNEY, AUSTRALIA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced that Marc Voigt, CEO will be presenting at two upcoming investor conferences:
Event:Â Â Â Â Bell Potter Healthcare Conference 2022Â Â Â Â Â Â Â Â
Date:Â Â Â Â Â...
>>> Read more: Immutep to Participate in Two Upcoming Investor Conferences
Media Release
SYDNEY, AUSTRALIA, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced that Marc Voigt, CEO will be presenting at two upcoming investor conferences:
Event:Â Â Â Â Bell Potter Healthcare Conference 2022Â Â Â Â Â Â Â Â
Date:Â Â Â Â Â...
>>> Read more: Immutep to Participate in Two Upcoming Investor Conferences
